Author:
Singh Satvir,Kaur Manpreet,Bhandari Divya,Kaur Mandeep,Gupta Monika
Abstract
1, 3, 4-oxadiazoles first came into the lime light about 80 years ago. With the increasing world population, the number of microbial infections has increased all over. To overcome the continuously spreading harmful microbial infections, the need for newer and newer drugs has increased tremendously. 1, 3, 4- oxadiazoles have been researched for the above mention purpose, because this nucleus has proven beneficial in a number of microbial infections from time to time. In the present review, we are highlight the biological activities being shown by the 1, 3, 4- oxadiazoles.
Publisher
Indian Drug Manufacturers' Association (IDMA)
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference40 articles.
1. 1. Hill J., 1, 3, 4-oxadiazole. Comp. Het. Chem. II 1996, 267-87.
2. 2. Sharma S., Sharma P. K., Kumar N., Dudhe R., A Review: Oxadiazole their chemistry and pharmacological potentials. Der Pharma Chemica 2010, 2(4). 253-263.
3. 3. Kavitha S., Gnanavel S., Kannan K., Biological aspects of 1, 3, 4-oxadiazole derivatives. Asian J. Pharm. Clin. Res. 2014, 7(4). 11-20.
4. 4. Mochona B., Qi X., Euynni S., Sikazwi D., Mateeva N., Soliman K. F., Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents. Bioorg. Med. Chem. Lett. 2016, 1-5.
5. 5. Dhumal S. T., Deshmukh A. R., Bhosle M. R., Khedkar V. M., Nawale L. U., Sarkar D. et al., Synthesis and Antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds. Bioorg. & Med. Chem. Ltrs. 2016.